References Appendices


  1. World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test [Internet]. Geneva; 2011
    http://whqlibdoc.who.int/publications/2011/9789241501569_eng.pdf

  2. Giusti, G. (1974). Adenosine deaminase. In Bergmeyer, H.U. (ed). Method of enzymatic analysis, Vol. II VCH Weinheim. Florida. P1072 . Rajesh Baheti, Purnima Ladha, RS Gehlot Indian Academy of Clinical Medicine. Vol.2(4): 285-287; Oct. Dec. 2001[12]

  3. Burgess LJ, Maritz FJ, Le Roux I, Taljaard JJ. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis. Chest 1996; 109:414.

  4. Riquelme A, Calvo M, Salech F, et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol 2006; 40:705.

  5. PIH Guide on the Medical management of MDR-TB, Partners In Health, Boston. 2003
    http://whqlibdoc.who.int/publications/2009/9789241547765_eng.pdf

  6. Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008: Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, Second Edition.
    http://www.currytbcenter.ucsf.edu/drtb/

  7. Centers for Disease Control and Prevention, American Thoracic Society, Infectious Diseases Society of America. Treatment of tuberculosis. Morbidity and Mortality Weekly Report, 2003, 52(RR11):1–77.

  8. World Health Organization. Guidelines for the Programmatic Management of Drug- Resistant Tuberculosis. Emergency Update 2008. (WHO/HTM/TB/2008.402)
    http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf

  9. I Coker, E Nardell, B Fourie, P Brickner, S Parsons, N Bhagwandin and P Onyebujoh. Guidelines for the Utilisation of Ultraviolet Germicidal Irradiation technology in controlling transmission of tuberculosis in health care facilities in South Africa. MRC.
    http://www.sahealthinfo.org/tb/guidelines.pdf

  10. Xu P. Ultraviolet germicidal irradiation for preventing infectious disease transmission. Boulder, CO: University of Colorado, Department of Civil, Environmental, and Architectural Engineering; 2001.

  11. Collins FM. Relative susceptibility of acid-fast and non-acid-fast bacteria to ultraviolet light. Appl Microbiol 1971;21:411–3.

  12. Kethley TW, Branch K. Ultraviolet lamps for room air disinfection. Effect of sampling location and particle size of bacterial aerosol. Arc Environ Health 1972;25:205–14.

  13. Riley RL, Permutt S. Room air disinfection by ultraviolet irradiation of upper air. Air mixing and germicidal effectiveness. Arch Environ Health 1971;22:208–19.

  14. Riley RL, Kaufman JE. Air disinfection in corridors by upper air irradiation with ultraviolet. Arch Environ Health 1971;22:551–3.

  15. Ko G, First MW, Burge HA. The characterization of upper-room ultraviolet germicidal irradiation in inactivating airborne microorganisms. Environmental Health Perspectives 2002;110:95–101.

  16. Ko G, First MW, Burge HA. Influence of relative humidity on particle size and UV sensitivity of Serratia marcescens and Mycobacterium bovis BCG aerosols. Tubercle Lung Dis 2000;80:217–28.

  17. Peccia J, Werth HM, Miller S, Hernandez M. Effects of relative humidity on the ultraviolet induced inactivation of airborne bacteria. Aerosol Science and Technology 2001;35:728–40.

  18. Riley RL, Kaufman JE. Effect of relative humidity on the inactivation of airborne Serratia marcescens by ultraviolet radiation. Appl Microbiol 1972;23:1113–20.

  19. First MW, Nardell EA, Chaisson W, Riley R. Guidelines for the application of upper-room ultraviolet germicidal irradiation for preventing transmission of airborne contagion—part I: basic principles. ASHRAE Trans 1999:105:869–876.

  20. Riley RL, Nardell EA [1989]. Clearing the air: the theory and application of ultraviolet air disinfection. Am Rev Respir Dis 139(5):1286–1294.

  21. WHO. Policy on TB Infection Control, 2009.
    http://whqlibdoc.who.int/publications/2009/9789241547857_eng.pdf

  22. Fallo A, Torrado L, Sánchez A, Cerqueiro C, Schargrodsky L, López EL. Delayed complications of Bacillus Calmette-Guérin (BCG) vaccination in HIV-infected children. In: International AIDS Society Conference, Rio de Janeiro, 24–27 July 2005.
    http://www.ias-2005.org/planner/Presentations/ppt/749.ppt

  23. Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PEM, et al., et al. The risk of disseminated Bacille Calmette-Guérin (BCG) disease in HIV-infected children. Vaccine 2007; 25: 14-8 doi: 10.1016/j.vaccine.2006.07.020 pmid:16959383.

  24. Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, et al., et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006; 42: 548-58 doi: 10.1086/499953pmid: 16421800.